Bruker enables scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, productivity and customer success in life science molecular research, in applied and pharma applications, and in microscopy, nano-analysis and industrial applications.
In recent years, Bruker has become a provider of high-performance systems for cell biology, preclinical imaging, clinical phenomics and proteomics research, clinical microbiology, and for molecular pathology research.
Bruker offers solutions in the following categories:
- Mass Spectrometry and Separations
- Preclinical Imaging
- Superconductors and Metal Composite Materials
- Infrared, Near Infrared and Raman Spectroscopy
- Fluorescence Microscopy
- Molecular Diagnostics
- X-ray Diffraction and Elemental Analysis
- Surface Plasmon Resonance
- Magnetic Resonance
- CBRNE Detection
- Arxspan Laboratory Software
- Surface and Dimensional Analysis
- Semiconductor Metrology
THU, SEP 24, 2020
Dr. Marty Pagel introduces the CEST MRI technique, demonstrates a basic experiment, and explains why measuring protein, acid, and metabolite content can be so beneficial in applications of brain ischemia and cancer.
Dr. Malmstrøm demonstrates how correlations between NMR data and bioactivity can be used to confirm the structure and activity of proteins.
Join Dr. Yongchao Su for an overview of the versatile roles of ssNMR in pharmaceutical development, providing a structural basis for the design of drug substances and products.
Dr. Sharman explains the impact of using NMR for the quality control and release of drug molecules currently in shortage due to the Coronavirus pandemic.
An expert in pharmaceutical sciences discusses solid-state NMR spectroscopy as an advanced analytical technique to provide unique insight into the composition and properties of pharmaceutical formulations.
Renowned MRI expert, Prof. Jim Wild, will discuss the clinical applications of 129Xe lung imaging with a focus on novel pulmonary therapies using hyperpolarized gas and proton lung MRI as markers.
An infectious lung disease expert shares compelling evidence for the use of micro-CT to repeatedly evaluate disease progression and therapy efficacy in live animals.
Experts discuss the synergies and implementation of state-of-the-art hybrid PET/MR technology and the new avenues of exploration it affords in the fields of neuroscience, cancer, and metabolic disease through to dual molecular probe development.
An expert from AstraZeneca will discuss the use of antibody drugs, how they function and the different techniques used to characterize them in the drug development process.
Dr. Redente discusses the advantages of microCT and provides a broad overview of pulmonary disease imaging using a highly innovate technique to analyze living animals, as well as fixed tissue.
Experts provide a guided tour to PET image reconstruction for the application-oriented user. They share the pros and cons, and give you a glimpse of what to expect in the future with exciting insights into future trends.
Scientists discuss the use of NMR to analyze the antiviral drug Azidothymidine AZT, a medication currently used to prevent and treat HIV/AIDS.